FORM 10-Q/A

                                  United States
                       Securities and Exchange Commission
                             Washington, D. C. 20549

 (Mark One)
      X         Quarterly Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                      For Quarter Ended: November 30, 2002
                                       OR
      _         Transition Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                         Commission File Number: 0-14820

                                  IMMUCOR, INC.
             (Exact name of registrant as specified in its charter)

                Georgia                                22-2408354
       (State or other jurisdiction of              (I.R.S. Employer
       incorporation or organization)              Identification No.)

          3130 Gateway Drive P.O. Box 5625 Norcross, Georgia 30091-5625
          (Address of principal executive offices)           (Zip Code)

                  Registrant's telephone number: (770) 441-2051

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                                    Yes X     No

     Indicate by check mark whether the registrant is an  accelerated  filer (as
defined in Rule 12b-2 of the Exchange Act).

                                    Yes       No X

     Indicate the number of shares  outstanding of each of the issuer's  classes
of common stock, as of the latest practicable date.

       As of December 31, 2002: Common Stock, $0.10 Par Value - 12,603,252

Immucor, Inc. is filing this amendment to its report on Form 10-Q for the fiscal quarter ended November 30, 2002 for the sole purpose of revising the last sentence of Note 2 to the unaudited consolidated financial statements contained therein. The phrase “three and six-month period” should have read “six-month period.” The sentence as amended reads:

“The effect of the adjustment was to increase net income by approximately $354,000, or $0.03 per share (basic and diluted) for the six-month period ended November 30, 2002.”

                                  IMMUCOR, INC.
                                  (Registrant)




Date: January 15, 2003         By:  /s/ Edward L. Gallup________
                                    Edward L. Gallup, President and Chief Executive Officer
                                    (on behalf of Registrant and as Principal Executive Officer)





                                    /s/ Steven C. Ramsey________
                                    Steven C. Ramsey, Senior Vice President - Finance
                                    (Principal Accounting Officer)

                                                            CERTIFICATIONS


I, Edward L. Gallup, certify that:


1.    I have reviewed this quarterly report on Form 10-Q of Immucor, Inc.;


2.   Based on my knowledge,  this quarterly report does not contain any untrue statement of a material fact or omit to state a material
     fact necessary to make the statements  made, in light of the  circumstances  under which such statements were made, not misleading
     with respect to the period covered by this quarterly report;


3.   Based on my knowledge,  the financial  statements,  and other  financial  information  included in this quarterly  report,  fairly
     present in all material respects the financial  condition,  results of operations and cash flows of the registrant as of, and for,
     the periods presented in this quarterly report;


4.   The  registrant's  other  certifying  officers and I are responsible for  establishing  and  maintaining  disclosure  controls and
     procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:


     a)  designed such disclosure  controls and procedures to ensure that material  information  relating to the registrant,  including
         its consolidated  subsidiaries,  is made known to us by others within those entities,  particularly during the period in which
         this quarterly report is being prepared;


     b)  evaluated the  effectiveness of the registrant's  disclosure  controls and procedures as of a date within 90 days prior to the
         filing date of this quarterly report (the "Evaluation Date"); and


     c)  presented in this quarterly report our conclusions  about the  effectiveness  of the disclosure  controls and procedures based
         on our evaluation as of the Evaluation Date;


5.   The  registrant's  other  certifying  officers and I have  disclosed,  based on our most recent  evaluation,  to the  registrant's
     auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):


     a)  all significant  deficiencies in the design or operation of internal  controls which could adversely  affect the  registrant's
         ability to record,  process,  summarize  and report  financial  data and have  identified  for the  registrant's  auditors any
         material weaknesses in internal controls; and


     b)  any  fraud,  whether  or not  material,  that  involves  management  or other  employees  who have a  significant  role in the
         registrant's internal controls; and


6.   The  registrant's  other  certifying  officers and I have indicated in this quarterly report whether or not there were significant
     changes in internal controls or in other factors that could  significantly  affect internal controls subsequent to the date of our
     most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.


Date: January 15, 2003




/s/ Edward L. Gallup
Edward L. Gallup,
President (Principal Executive Officer)

I, Steven C. Ramsey, certify that:


1.   I have reviewed this quarterly report on Form 10-Q of Immucor, Inc.;


2.   Based on my knowledge,  this quarterly report does not contain any untrue statement of a material fact or omit to state a material
     fact necessary to make the statements  made, in light of the  circumstances  under which such statements were made, not misleading
     with respect to the period covered by this quarterly report;


3.   Based on my knowledge,  the financial  statements,  and other  financial  information  included in this quarterly  report,  fairly
     present in all material respects the financial  condition,  results of operations and cash flows of the registrant as of, and for,
     the periods presented in this quarterly report;


4.   The  registrant's  other  certifying  officers and I are responsible for  establishing  and  maintaining  disclosure  controls and
     procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:


     a)  designed such disclosure  controls and procedures to ensure that material  information  relating to the registrant,  including
         its consolidated  subsidiaries,  is made known to us by others within those entities,  particularly during the period in which
         this quarterly report is being prepared;


     b)  evaluated the  effectiveness of the registrant's  disclosure  controls and procedures as of a date within 90 days prior to the
         filing date of this quarterly report (the "Evaluation Date"); and


     c)  presented in this quarterly report our conclusions  about the  effectiveness  of the disclosure  controls and procedures based
         on our evaluation as of the Evaluation Date;


5.   The  registrant's  other  certifying  officers and I have  disclosed,  based on our most recent  evaluation,  to the  registrant's
     auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):


     a)  all significant  deficiencies in the design or operation of internal  controls which could adversely  affect the  registrant's
         ability to record,  process,  summarize  and report  financial  data and have  identified  for the  registrant's  auditors any
         material weaknesses in internal controls; and


     b)  any  fraud,  whether  or not  material,  that  involves  management  or other  employees  who have a  significant  role in the
         registrant's internal controls; and


6.   The  registrant's  other  certifying  officers and I have indicated in this quarterly report whether or not there were significant
     changes in internal controls or in other factors that could  significantly  affect internal controls subsequent to the date of our
     most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.


Date: January 15, 2003




/s/ Steven C. Ramsey
Steven C. Ramsey,
Senior Vice President - Finance (Principal Financial Officer)

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

In connection with the Quarterly Report of Immucor, Inc. (the “Company”) on Form 10-Q for the period ended November 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward L. Gallup, President (Chief Executive Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

        (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

        (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward L. Gallup

Edward L. Gallup
President (Chief Executive Officer)

January 15, 2003

Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

In connection with the Quarterly Report of Immucor, Inc. (the“Company”) on Form 10-Q for the period ended November 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven C. Ramsey, Senior Vice President - Finance (Chief Accounting Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

        (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

        (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Steven C. Ramsey

Steven C. Ramsey
Senior Vice President - Finance (Chief Financial Officer)

January 15, 2003